Mostly Markets
Subscribe
Stocks/Health Care/Pharmaceuticals

AstraZenecaAZN

Pharmaceuticals
$186.65+7.02%After hours: $186.35 (−0.16%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 14.0% over 1 year
AstraZeneca over 1 yearDaily close, $, to 30 Oct 2026
$160$180$200Nov2026MarMayJulSep$186.65$160$180$200NovMarJul$186.65
Source: Nasdaq daily closes
Market value$290B
Price to earnings26.2x
Forward P/E17.5x
Dividend yield1.73%
Year to date+6.4%
One year+14.0%
Next earningsNot scheduled
SectorHealth Care
52-week range (closes)
$155.62$209.48

Quality and valuation

How AstraZeneca compares with other health care stocks. A description, not a recommendation.

AstraZeneca and 4 pharmaceuticals peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Valuation: in line with its sector

Next to other health care companies, it is, priced about in line with them.

AstraZeneca trades at 17.5 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover.

    AZN trades at 17.5x forward earnings, below the sector medianForward p/e, Pharmaceuticals peers
    BMY10.5xPFE11.1xNVO12.2xNVS17.0xAZN17.5xMRK18.1xJNJ25.1xLLY36.3xSector median 19.1xBMY10.5xPFE11.1xNVO12.2xNVS17.0xAZN17.5xMRK18.1xJNJ25.1xLLY36.3xSector median 19.1x
    Source: CNBC quotes; Mostly Markets

    Stories on AstraZeneca

    We haven't written about AstraZeneca yet. Follow it, and its first story will show under My stocks on the front page.

    Similar companies

    Pharmaceuticals, by market value.

    CompanyPriceTodayYTDValue
    LLYEli Lilly$1,417.54+3.19%+31.9%$1.33T
    JNJJohnson & Johnson$273.20−0.73%+32.0%$658B
    MRKMerck$149.52+2.18%+42.0%$369B
    NVSNovartis$160.79−0.19%+16.6%$327B
    PFEPfizer$30.52+1.90%+22.6%$174B
    NVONovo Nordisk$40.00+2.20%−21.4%$136B
    BMYBristol Myers Squibb$62.48+1.78%+15.8%$128B
    ZTSZoetis$79.72+1.85%−37.4%$32.94B